Rheumatoid Arthritis Market is expected to increase from $56.6 billio Rheumatoid Arthritis Market 2020 | Page 4

2.10.1 Pharmacological 16
2.10.2 Methotrexate 16
2.10.3 Plaquenil (hydroxychloroquine) 16
2.10.4 Arava (leflunomide) 16
2.10.5 Azulfidine, Salazopyrin (sulfasalazine) 17
2.10.6 Neoral (cyclosporine) 17
2.10.7 Prograf (tacrolimus) 17
2.10.8 Xeljanz (tofacitinib) 17
2.11 Other Non-biologics 17
2.11.1 Non-steroidal Anti-inflammatory Drugs 17
2.11.2 Painkillers 18
Read Complete Report with TOC @ http://www.radiantinsights.com/research/rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
2.11.3 Glucocorticoids 18
2.12 Biologic Disease-Modifying Anti-rheumatic Drugs 18
2.12.1 Tumor Necrosis Factor Alpha Inhibitors 18
2.12.2 Interleukin Inhibitors 18
2.12.3 Other Biologics that Target B- and T-Cell Antigens 19
2.13 Disease Scoring Methods for Measuring Treatment Efficacy 19
2.13.1 Radiographic Progression 19
2.13.2 Clinical Disease Activity Index and Simplified Disease Activity Index 19
2.13.3 Disease Activity Score-28 19
2.13.4 American College of Rheumatology 20
2.13.5 Health Assessment Questionnaire 20

3 Marketed Products 21